PD0325901, an ERK inhibitor, attenuates RANKL‐induced osteoclast formation and mitigates cartilage inflammation by inhibiting the NF-κB and MAPK pathways

p38MAPK Signaling Pathway in Osteoarthritis: Pathological and Therapeutic Aspects

(2022) Zongchao Li et al.   Journal of Inflammation Research

Structural changes in the collagen network of joint tissues in late stages of murine OA

(2022) Natalie K. Yoshioka et al.   Scientific Reports

Intra-articular Injection of Baicalein Inhibits Cartilage Catabolism and NLRP3 Inflammasome Signaling in a Posttraumatic OA Model

(2021) Hui Bai et al.   Oxidative Medicine and Cellular Longevity

NLRP3 inflammasome activation mediates sleep deprivation-induced pyroptosis in mice

(2021) Kun Fan et al.   PeerJ

IL-1α and IL-1β promote NOD2-induced immune responses by enhancing MAPK signaling

(2019) Sushan Li et al.   LABORATORY INVESTIGATION

Intraarticular Ligament Degeneration Is Interrelated with Cartilage and Bone Destruction in Osteoarthritis

(2019) Gundula Schulze-Tanzil   Cells

The role of matrix metalloproteinases in osteoarthritis pathogenesis: An updated review

(2019) El-Sayed E. Mehana et al.   LIFE SCIENCES

Cartilage regeneration and ageing: Targeting cellular plasticity in osteoarthritis

(2018) Marta Varela-Eirin et al.   AGEING RESEARCH REVIEWS

Osteoarthritis as a disease of the cartilage pericellular matrix

(2018) Farshid Guilak et al.   MATRIX BIOLOGY

Osteoporosis in 2017: Addressing the crisis in the treatment of osteoporosis

(2018) Christian Roux et al.   Nature Reviews Rheumatology

Interleukin-1β signaling in osteoarthritis – chondrocytes in focus

(2018) Zsuzsa Jenei-Lanzl et al.   CELLULAR SIGNALLING

Selective MMP-13 inhibitors: promising agents for the therapy of Osteoarthritis

(2018) Yichao Wan et al.   CURRENT MEDICINAL CHEMISTRY

Osteoarthritis: toward a comprehensive understanding of pathological mechanism

(2017) Di Chen et al.   Bone Research

Preserving the longevity of long-lived type II collagen and its implication for cartilage therapeutics

(2016) Moti L. Tiku et al.   AGEING RESEARCH REVIEWS

The “love–hate” relationship between osteoclasts and bone matrix

(2016) Nadia Rucci et al.   MATRIX BIOLOGY

MEK inhibitors block growth of lung tumours with mutations in ataxia–telangiectasia mutated

(2016) Michal Smida et al.   Nature Communications

Osteoarthritis

(2015) S Glyn-Jones et al.   LANCET

Thymoquinone prevents RANKL-induced osteoclastogenesis activation and osteolysis in an in vivo model of inflammation by suppressing NF-KB and MAPK Signalling

(2015) Dinesh Thummuri et al.   PHARMACOLOGICAL RESEARCH

Endoplasmic reticulum stress-induced apoptosis contributes to articular cartilage degeneration via C/EBP homologous protein

(2014) Y. Uehara et al.   OSTEOARTHRITIS AND CARTILAGE

Modulation of endochondral ossification by MEK inhibitors PD0325901 and AZD6244 (Selumetinib)

(2013) J. El-Hoss et al.   BONE

Advances in the Regulation of Osteoclasts and Osteoclast Functions

(2013) B.F. Boyce   JOURNAL OF DENTAL RESEARCH

Meniscus pathology, osteoarthritis and the treatment controversy

(2012) Martin Englund et al.   Nature Reviews Rheumatology

Articular cartilage and subchondral bone in the pathogenesis of osteoarthritis

(2010) Mary B. Goldring et al.   Annals of the New York Academy of Sciences

The p38 MAPK inhibitors for the treatment of inflammatory diseases and cancer

(2009) Hae-Young Yong et al.   EXPERT OPINION ON INVESTIGATIONAL DRUGS